Pharmacology: Medication Uses and Actions

Ibuprofen/Naproxen

  • Use:

    • Indicated for mild to moderate pain and antipyretic (fever reduction).

  • Action:

    • Provides non-selective reversible inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which are vital in the production of prostaglandins involved in pain and inflammation.

  • Route:

    • Administered orally (PO) and intravenously (IV).

  • Adverse Effects (AEs):

    • Gastrointestinal (GI) issues, ulcerations, nephrotoxicity (elevated blood urea nitrogen [BUN]/creatinine).

  • Contraindications (Con):

    • Presence of allergies to non-steroidal anti-inflammatory drugs (NSAIDs) and salicylates.

  • Nursing Interventions (NI):

    • Do not exceed 3200 mg daily and advise to take with food to minimize GI discomfort.

Morphine

  • Use:

    • Effective for relief of moderate to severe pain.

  • Action:

    • Binds to opioid receptors in the central nervous system (CNS) and peripheral nervous system (PNS) to inhibit pain signals.

  • Route:

    • Administered orally (PO), intramuscularly (IM), subcutaneously (SC), or via transdermal patches (noting to give IV opioids slowly over 5 minutes).

  • Adverse Effects (AEs):

    • Respiratory depression leading to sedation, autonomic nervous system (ANS) effects on GI and bladder function, CNS side effects, and itching reactions.

  • Contraindications (Con):

    • Respiratory depression confirmed with a respiratory rate (RR) of less than 12 breaths per minute.

  • Nursing Interventions (NI):

    • Stop administration if RR is below 12 and have naloxone available as a resuscitation medication.

Aspirin

  • Use:

    • Utilized in anti-platelet therapy and for mild to moderate pain relief.

  • Action:

    • Irreversibly inhibits COX-1 and COX-2 enzymes, lowering the production of inflammatory prostaglandins.

  • Route:

    • Administered orally (PO), intravenously (IV), or rectally.

  • Adverse Effects (AEs):

    • Gastrointestinal complications, hematologic implications, possible hearing loss, toxicity, and rash. Special concern for children due to the risk of Reye Syndrome.

  • Contraindications (Con):

    • Known hypersensitivity, history of bleeding disorders, and a maximum daily dosage of 8000 mg.

  • Nursing Interventions (NI):

    • Assess pain on a scale, avoid crushing the tablet, advise to take with food, and assess for prior allergies.

Digoxin

  • Use:

    • Second-line therapy for mild to moderate heart failure (HF) and in managing arterial fibrillation.

  • Action:

    • Enhances cardiac contractility, thereby improving cardiac output and increasing the force of contraction.

  • Adverse Effects (AEs):

    • Toxicity characterized by serum levels exceeding 2.0 mg/mL causing anorexia, nausea, and vision changes (yellow/green halos).

  • Contraindications (Con):

    • Dysrhythmias and noted on the BEERS list for caution in older adults.

  • Nursing Interventions (NI):

    • Avoid giving with dairy or antacids, be cautious with furosemide, administer IV over 5 minutes, and monitor potassium levels due to heightened toxicity danger with low potassium (K+). The antidote for toxicity is digoxin immune fab.

Furosemide (Lasix)

  • Use:

    • Treatment of severe heart failure; acts as a diuretic to promote sodium and fluid loss.

  • Action:

    • Inhibits sodium chloride (NaCl) reabsorption in the ascending loop of Henle in the kidneys.

  • Adverse Effects (AEs):

    • Electrolyte imbalance (notably decreased K+), hypotension, and potential ototoxicity.

  • Contraindications (Con):

    • Allergy to sulfa drugs, caution in older adults, and pregnancy category C.

  • Nursing Interventions (NI):

    • Monitor daily fasting weight and glucose levels, and infuse IV over 1-2 minutes. Note the interaction with digoxin can heighten the risk of toxicity.

Low-Dose Aspirin

  • Use:

    • To decrease the rate of vascular clotting.

  • Action:

    • Inhibits cyclooxygenase enzyme in thromboxane at low doses (91-325 mg/day).

  • Nursing Interventions (NI):

    • Report any signs of bleeding, advice to take with or after meals.

t-PA (Alteplase)

  • Use:

    • Employed for reperfusion therapy in cases of ischemic stroke.

  • Action:

    • Dissolves blood clots and stimulates the conversion of plasminogen (produced by the liver) to plasmin, a fibrinolytic protein.

  • Adverse Effects (AEs):

    • Risk of bleeding of any type and cardiac arrhythmias.

  • Contraindications (Con):

    • Active current anticoagulant therapy and bleeding tendencies.

  • Nursing Interventions (NI):

    • Ensure consent form is signed, avoid subcutaneous or intramuscular injections, monitor for bleeding, and administer at 0.9 mg/kg body weight.

Atorvastatin

  • Use:

    • First-line therapy as an HMG-CoA reductase inhibitor to manage cholesterol.

  • Action:

    • Inhibits the enzyme necessary for the hepatic synthesis of cholesterol, thus lowering LDL cholesterol levels.

  • Adverse Effects (AEs):

    • GI symptoms, muscle-related complaints, and hepatotoxicity.

  • Contraindications (Con):

    • Contraindicated in pregnancy and liver disease.

  • Nursing Interventions (NI):

    • Administer in the evening, cease use if muscle pain, tenderness, or weakness arises, and avoid grapefruit due to interaction.

Spironolactone (Aldactone)

  • Use:

    • Prescribed for hypertension (HBP) and heart failure, often used with other medications to reduce potassium loss.

  • Action:

    • Blocks aldosterone receptors in the kidneys, leading to potassium retention.

  • Adverse Effects (AEs):

    • Risk of hyperkalemia, low sodium (Na+), and potential for tumor growth.

  • Contraindications (Con):

    • Increased potassium levels, renal or liver disease.

  • Nursing Interventions (NI):

    • Monitor for hyperkalemia, sodium and potassium levels, avoid grapefruit, and typically used with furosemide.

Propranolol

  • Use:

    • Treatment for hypertension (HTN) and heart failure (HF).

  • Action:

    • Blocks beta-adrenergic receptors leading to decreased heart rate (HR), contractility, blood pressure (BP), and renin release, inducing vasodilation.

  • Adverse Effects (AEs):

    • Risk for bradycardia, bronchospasm (wheezing), and orthostatic hypotension. Black box warning against abrupt cessation, especially in patients with coronary artery disease (CAD).

  • Contraindications (Con):

    • Caution required in asthma and chronic obstructive pulmonary disease (COPD) patients as it may mask severe hypoglycemia.

  • Nursing Interventions (NI):

    • Measure apical pulse and blood pressure prior to administration; withhold if pulse is below 50-60 bpm.

Lisinopril

  • Action:

    • Blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.

  • Adverse Effects (AEs):

    • May cause a dry persistent cough, hyperkalemia, and angioedema.

  • Contraindications (Con):

    • Pregnancy category D, renal artery stenosis, and historical angioedema.

  • Nursing Interventions (NI):

    • Monitor blood pressure, heart rate, BUN/creatinine, and potassium levels; discontinue if angioedema occurs.

Ciprofloxacin

  • Use:

    • Effective for treating sinusitis, pneumonia, lower respiratory infections, and urinary tract infections (UTI).

  • Route:

    • Administered orally (PO) or intravenously (IV).

  • Adverse Effects (AEs):

    • Gastrointestinal symptoms, headache, dizziness, photosensitivity, and a black box warning for potential Achilles tendon rupture.

  • Contraindications (Con):

    • Caution advised in renal disease; contraindicated in patients under 18 years of age.

  • Nursing Interventions (NI):

    • Instruct to stop and report any discomfort in the Achilles tendon area.

Clindamycin (Cleocin)

  • Use:

    • Topically used for treating acne and cocci infections.

  • Route:

    • Administered topically or orally (PO).

  • Adverse Effects (AEs):

    • Nausea/vomiting and a black box warning for potential colitis.

  • Contraindications (Con):

    • Caution in patients with liver impairment.

  • Nursing Interventions (NI):

    • Take with water and avoid refrigeration of the medication.

Cephalosporin (Cefazolin)

  • Use:

    • Utilized for surgical prophylaxis.

  • Action:

    • Inhibits the structural integrity of the bacterial cell wall, providing a broad-spectrum antibiotic activity.

  • Route:

    • Available in PO, IM, or IV forms.

  • Adverse Effects (AEs):

    • Hypersensitivity reactions, gastrointestinal (GI) side effects, genitourinary (GU) issues, renal insufficiency, and bleeding.

  • Contraindications (Con):

    • Patients with a history of penicillin allergy should use with caution.

  • Nursing Interventions (NI):

    • Monitor for diarrhea and stop due to the risk of Clostridium difficile infection; assess for possible cross-sensitivities due to structural similarities with penicillin.

Metronidazole

  • Use:

    • Treats Clostridium difficile infections and helps to prevent infections during abdominal surgeries.

  • Route:

    • Administered by PO, IV, or topical application.

  • Adverse Effects (AEs):

    • Risk of yeast infections and a metallic taste in the mouth.

  • Contraindications (Con):

    • Assess for hypersensitivity, use during pregnancy with caution, and caution in CNS, blood, or liver diseases.

  • Nursing Interventions (NI):

    • Advise against alcohol consumption as it may lead to adverse reactions, monitor for allergies, and be aware of numerous drug interactions; urine may appear dark reddish-brown.

1st Generation Antihistamines (Diphenhydramine)

  • Use:

    • Used for allergic reactions and as a cough suppressant.

  • Action:

    • Competes with histamine for receptor sites on effector cells, reducing allergic responses.

  • Route:

    • Administered orally (PO), IM, IV, or topically.

  • Adverse Effects (AEs):

    • Sedation, drowsiness, and anticholinergic effects such as urinary retention.

  • Contraindications (Con):

    • Use with caution during breastfeeding, in the elderly, and in patients with asthma/COPD.

  • Nursing Interventions (NI):

    • Monitor for allergy symptoms and advise to take with or without food, drinking milk to mitigate GI upset.

Vancomycin

  • Use:

    • Indicated for serious Gram-positive infections, for example, Methicillin-resistant Staphylococcus aureus (MRSA).

  • Action:

    • A bacterial agent effective only against Gram-positive bacteria, inhibiting cell wall synthesis.

  • Route:

    • Administered IV slowly (over 1-2 hours) and orally for Clostridium difficile infections.

  • Adverse Effects (AEs):

    • Nephrotoxicity, ototoxicity, and vancomycin infusion reactions.

  • Contraindications (Con):

    • Allergy to corn and renal impairments.

  • Nursing Interventions (NI):

    • Monitor renal function and hearing, check peak-trough levels, and assess for flushing, redness, or rash post-infusion.

Penicillin

  • Use:

    • Used to prevent infective endocarditis.

  • Action:

    • Bactericidal in nature, it inhibits bacterial cell wall synthesis and has a broad-spectrum effect.

  • Route:

    • Administered via IM or IV routes.

  • Adverse Effects (AEs):

    • Hypersensitivity reactions, rashes, GI discomfort, and a black box warning regarding decreased potassium levels.

  • Contraindications (Con):

    • Allergies to penicillin (noting that if allergic to one form, risks allergy to all are elevated), and increased caution in those with known cephalosporin sensitivity.

  • Nursing Interventions (NI):

    • Document and know patient allergies, monitor for side effects, and be aware of the risk of fatal anaphylaxis.

Gentamicin

  • Use:

    • Administered for serious systemic infections through IM or IV.

  • Action:

    • Binds to the 30s subunit of bacterial ribosomes, inhibiting protein synthesis in bacteria.

  • Adverse Effects (AEs):

    • Potential hearing loss, nephrotoxicity especially in patients taking muscle relaxants or anesthesia, and ototoxicity.

  • Contraindications (Con):

    • Hypersensitivity and caution required in older adults due to renal impairment risks.

  • Nursing Interventions (NI):

    • Monitoring is necessary due to its narrow therapeutic window, requiring peak-trough measurement, and should not be administered for more than 10 days.